Dr. Anthony Guiseppi-Elie | |
---|---|
Born | Trinidad and Tobago | October 8, 1954
Alma mater | Massachusetts Institute of Technology (MIT) - Sc.D. and Postdoctoral Fellow, University of Manchester Institute of Science and Technology (UMIST) - M.Sc., University of West Indies - B.Sc. (First Class Honors) |
Spouse | Annette Guiseppi-Elie |
Children | Adilah Guiseppi-Wilson |
Scientific career | |
Fields | Bioelectronics, Biochips, Nano and Microfabrication, BioMEMs, Bioanalytical Microsystems, Electomics |
Institutions | Tri-County Technical College, Anderson University, Texas A&M University, Clemson University, Virginia Commonwealth University, Johns Hopkins University, ABTECH Scientific, Inc., Molecular Electronics Corporation, W.R. Grace and Co |
Anthony "Tony" Guiseppi-Elie is a Trinidad-born, American scientist, engineer, entrepreneur, and avid Wikipedia editor. He is the President and Sr. Fellow of the American International Institute of Medical Sciences, Engineering and Innovation and the President and Scientific director of ABTECH Scientific, Inc. [1] [2] He is noted for his research and commercial development of biologically inspired and chemically responsive electroconductive hydrogels. [3] [4] Guiseppi-Elie is the Founding Editor-in-Chief of the transdisciplinary journal Bioengineering . [5]
He is a co-founder of the convergent academic program in engineering and medicine (School of ENMED) [6] at Texas A&M University. He is also the Founding Dean of the convergent liberal-arts and engineering programs of the College of Engineering at Anderson University (South Carolina).
Guiseppi-Elie was born and raised in Trinidad and Tobago. He is an alumnus of North Eastern College (Sande Grande, Trinidad, Trinidad and Tobago). He earned a B.Sc. (First Class Honors) with triple majors in Applied Chemistry, Analytical Chemistry, and Biochemistry from the University of the West Indies. He was awarded a Commonwealth Scholarship and a UWI Bursary to attend the University of Manchester Institute of Science and Technology (UMIST), where he earned the M.Sc. in Chemical Engineering with a focus on corrosion science and engineering. He earned his Sc.D. in Materials Science and Engineering (III) / PPST/ PPSM from MIT, where he also completed a postdoctoral fellowship. Guiseppi-Elie and his wife have one daughter.
Following his graduate studies, where he focused on under-film corrosion protection by coatings for his M.Sc. and on the Synthesis and Characterization of Polyacetylene for his Sc.D., Dr. Anthony Guiseppi-Elie's career initially concentrated on chemical engineering and materials science and engineering. He spent the first fifteen years of his professional life in industrial research and product development, contributing to various organizations ranging from large corporations to startups. His corporate affiliations included W. R. Grace and Co., Molecular Electronics Corporation, Allage Associates Inc., AAI-ABTECH, and ABTECH Scientific, Inc.
Dr. Guiseppi-Elie then transitioned into academia, spending the next eighteen years as a tenured, titled, and endowed full professor at several notable universities, including Virginia Commonwealth University (VCU), Clemson University, Texas A&M University (TAMU), and Anderson University (South Carolina) (AUSC). At VCU, he served as a full professor of Chemical and Life Sciences Engineering and Emergency Medicine. He was also the director of a pioneering Department of Defense, Commonwealth of Virginia, and industry-supported transdisciplinary center that specialized in microfabricated DNA and protein biochips and diagnostic biosensors.
His tenure at Clemson University saw him occupy the role of Dow Chemical Professor in Chemical and Biomolecular Engineering. He was also a professor of Bioengineering and Electrical and Computer Engineering and led the center focusing on biosensors, bioelectronics, and nano-biotechnology. At TAMU, Dr. Guiseppi-Elie held the TEES Research Professorship in Engineering, was the head of the Department of Biomedical Engineering, and served as the founding associate dean of engineering innovation in the College of Engineering. [7] He co-founded the School of Engineering Medicine [8] and was a founding member of the Texas A&M Academy of Physician-Scientists. [9] At Anderson University, he was the university distinguished professor, vice president of industry relations, and founding dean of the college of engineering, where he developed a unique, industry-supported, convergent liberal-arts engineering curriculum.
Most recently, he served as the vice president of academic affairs and the chief academic officer at Tri-County Technical College. Alongside his academic career, Dr. Guiseppi-Elie has been involved with three startup companies and is the Founder, President, and Scientific Director of ABTECH Scientific, Inc. [10]
Dr. Anthony Guiseppi-Elie has been recognized with several prestigious awards and honors throughout his career:
In 2016, he was named the chair-elect of the American Institute for Medical and Biological Engineering (AIMBE) and served as the convening chair of the College of Fellows from 2017 to 2018. He was inducted as a fellow into AIMBE in 2006. [11] He was elected Fellow of the Biomedical Engineering Society (FBMES) in 2020, recognizing his contributions to engineering-medicine and implantable microsystems. [12] [13] In 2016, he was elected as a Fellow of the Institute of Electrical and Electronics Engineers (IEEE) Engineering in Medicine and Biology Society (FIEEE) for his contributions to organic electronic materials in biotechnology and biomedicine. [14] He was elected as a Fellow of the Royal Society of Chemistry (FRSC) in 2014, for his contributions at the interface of chemistry, materials chemistry, nano-science, and biotechnology. He became a Fellow of the American Institute for Medical and Biological Engineering (FAIMBE) in 2006 for his work on bio-smart materials based on electroconductive hydrogels. [15] He is a Life Member of the American Institute of Chemical Engineers (AIChE) and Sigma Xi. He was appointed as a Fulbright Specialist (2014-2019) by the U.S. Department of State's Bureau of Educational and Cultural Affairs (ECA) in the Fulbright Program and World Learning. [16] [17] He served as an IEEE-EMBS Distinguished Lecturer from 2012 to 2013. [18] He acted as the Convening Chair of the annual international Biomedical Engineering and Instrumentation conferences in Boston, Massachusetts, USA (2019, 2020, 2021, 2023, 2024). He was invited as a Distinguished Faculty Presenter at the NSF Bio-X Summer School and Advanced Institute, Orthodox Academy of Crete, Kolympari, Chania, Crete, Greece in 2019 and 2023.
Ali Khademhosseini is the CEO of the Terasaki Institute, non-profit research organization in Los Angeles, and Omeat Inc., a cultivated-meat startup. Before taking his current CEO roles, he spent one year at Amazon Inc. Prior to that he was the Levi Knight chair and professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering as well as the Director of Center for Minimally Invasive Therapeutics (C-MIT). From 2005 to 2017, he was a professor at Harvard Medical School, and the Wyss Institute for Biologically Inspired Engineering.
Leland C. Clark Jr. was an American biochemist born in Rochester, New York. He is most well known as the inventor of the Clark electrode, a device used for measuring oxygen in blood, water and other liquids. Clark is considered the "father of biosensors", and the modern-day glucose sensor used daily by millions of diabetics is based on his research. He conducted pioneering research on heart-lung machines in the 1940s and '50s and was holder of more than 25 patents. Although he developed a fluorocarbon-based liquid that could be breathed successfully by mice in place of air, his lifelong goal of developing artificial blood remained unfulfilled at the time of his death. He is the inventor of Oxycyte, a third-generation perfluorocarbon (PFC) therapeutic oxygen carrier designed to enhance oxygen delivery to damaged tissues.
Kevin J. Tracey, a neurosurgeon and inventor, is the president and CEO of the Feinstein Institute for Medical Research, professor of neurosurgery and molecular medicine at the Zucker School of Medicine, and president of the Elmezzi Graduate School of Molecular Medicine in Manhasset, New York. The Public Library of Science Magazine, PLOS Biology, recognized Tracey in 2019 as one of the most cited researchers in the world.
Joseph Wang is an American biomedical engineer and inventor. He is a Distinguished Professor, SAIC Endowed Chair, and former Chair of the Department of Nanoengineering at the University of California, San Diego, who specialised in nanomachines, biosensors, nano-bioelectronics, wearable devices, and electrochemistry. He is also the Director of the UCSD Center of Wearable Sensors and co-director of the UCSD Center of Mobile Health Systems and Applications (CMSA).
Bioelectronics is a field of research in the convergence of biology and electronics.
Nicholas (Nikolaos) A. Peppas is a chemical and biomedical engineer whose leadership in biomaterials science and engineering, drug delivery, bionanotechnology, pharmaceutical sciences, chemical and polymer engineering has provided seminal foundations based on the physics and mathematical theories of nanoscale, macromolecular processes and drug/protein transport and has led to numerous biomedical products or devices.
The American Institute for Medical and Biological Engineering (AIMBE) is a non-profit organization founded in 1991, and headquartered in Washington, D.C. It represents 50,000 medical and biomedical engineers, and academic institutions, private industry, and professional engineering societies.
Kristi S. Anseth is the Tisone Distinguished Professor of Chemical and Biological Engineering, an Associate Professor of Surgery, and a Howard Hughes Medical Investigator at the University of Colorado at Boulder. Her main research interests are the design of synthetic biomaterials using hydrogels, tissue engineering, and regenerative medicine.
Edward Wilson Merrill was an American biomaterials scientist. He was one of the founders of bioengineering, and specifically the biomedical engineering field it developed from chemical engineering. Merrill was born to Edward Clifton Merrill (1881–1949), a chemical engineer and chief chemist of the United Drug Company (Rexall) and Gertrude Wilson (1895–1978).
Biosensors and Bioelectronics is a peer-reviewed scientific journal published by Elsevier. It covers research on biosensors and bioelectronics. The journal was established in 1985 as Biosensors and obtained its current name in 1991. The journal was established by I. John Higgins, W. Geoff Potter and Anthony P.F. Turner, who became editor-in-chief, until his retirement in 2019. The current Editors in Chief are Chenzhong Li, Arben Merkoçi, and Man Bock Gu.
Anthony Steven Weiss AM PhD FRSC FTSE FRSN FRACI, FTERM, FBSE is a university researcher, company founder and entrepreneur. He is the leading scientist in human tropoelastin research and synthetic human elastin. He holds the McCaughey Chair in Biochemistry, heads the Charles Perkins Centre Node in Tissue Engineering and Regenerative Medicine, and is Professor of Biochemistry and Molecular Biotechnology at the University of Sydney. His discoveries are on human elastic materials that accelerate the healing and repair of arteries, skin and 3D human tissue components. He is a Fellow of the Royal Society of Chemistry. Weiss is on the editorial boards of the American Chemical Society Biomaterials Science and Engineering, Applied Materials Today (Elsevier), Biomaterials, Biomedical Materials, BioNanoScience (Springer) and Tissue Engineering. He is a biotechnology company founder, promoter of national and international technology development, and has received national and international awards, including the Order of Australia.
Alan J. Russell, is Vice President of Biologics for Amgen, one of the world’s leading Biopharmaceutical companies. Until 2020, Alan was the Highmark Distinguished Career Professor and Director of the Disruptive Health Technology Institute at Carnegie Mellon University. From 2013 through spring of 2016 he was also the Chief Innovation Officer, Allegheny Health Network.
Akhilesh K. Gaharwar is an Indian academic and a professor in the Department of Biomedical Engineering at Texas A&M University.
Kristi Lynn Kiick is the Blue and Gold Distinguished Professor of Materials Science and Engineering at the University of Delaware. She studies polymers, biomaterials and hydrogels for drug delivery and regenerative medicine. She is a Fellow of the American Chemical Society, the American Institute for Medical and Biological Engineering, and of the National Academy of Inventors. She served for nearly eight years as the deputy dean of the college of engineering at the University of Delaware.
Philip LeDuc is the William J. Brown Professor at Carnegie Mellon University (CMU) and the Founding Director of its Center for the Mechanics and Engineering of Cellular Systems. He is in the department of Mechanical Engineering, but also has appointments in Biological Sciences, Computational Biology, Biomedical Engineering, and Electrical and Computer Engineering. LeDuc works at the intersection of mechanical engineering and biology.
Jerome Schultz is an American bioengineering researcher, professor, and university administrator. He is a fellow of several national scientific societies and a member of the National Academy of Engineering. He has held professorships at the University of Michigan, the University of Pittsburgh, University of California, Riverside, and he is currently a Distinguished Professor of Biomedical Engineering at the University of Houston.
Sina Y. Rabbany is the Jean Nerken Distinguished Professor of Engineering at Hofstra University, dean of the Fred DeMatteis School of Engineering and Applied Science, founding director of the school's Bioengineering program, and adjunct associate professor of bioengineering at the Weill Cornell Medical College of Cornell University. Under his tenure, the DeMatteis School's fast growth led to the school's planned expansion into a new Science and Innovation Center. His research concerns cellular and tissue engineering of the vascular system and investigates the impact of the biophysical microenvironment on the structure and function of endothelial cells. His research explores the capabilities of endothelial cells to build functional blood vessels and support organ regeneration. His h-index is 28 by Google Scholar.
Elizabeth Cosgriff-Hernandez is an American biomedical engineer who is a professor at the University of Texas at Austin. Her work involves the development of polymeric biomaterials for medical devices and tissue regeneration. She also serves on the scientific advisory board of ECM Biosurgery and as a consultant to several companies on biostability evaluation of medical devices. Cosgriff-Hernandez is an associate editor of the Journal of Materials Chemistry B and Fellow of the International Union of Societies for Biomaterials Science and Engineering, Biomedical Engineering Society, Royal Society of Chemistry, and the American Institute for Medical and Biological Engineering.
Chenzhong Li is a Chinese-born Canadian & American biomedical engineer, chemist, inventor, professor, and journal editor. Li is the co-Editor-in-Chief of the journal Biosensors and Bioelectronics (Elsevier) and the associate editors of journals RESEARCH (AAAS) and Biosensors (MDPI).
Melissa Ann Grunlan is an American scientist and academic. She is Professor and Holder of the Charles H. and Bettye Barclay Professorship in the Department of Biomedical Engineering at Texas A&M University. She holds courtesy appointments in the Departments of Chemistry and Materials Science & Engineering. Her research focuses on the development of polymeric biomaterials for regenerative engineering and medical devices.
{{cite web}}
: Missing or empty |title=
(help){{cite web}}
: Missing or empty |title=
(help){{cite web}}
: Missing or empty |title=
(help)